Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
AO ›
AOLIV
Trademark search for:
AOLIV
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-05-20 — Application filed
2015-05-23 — Application filed
2015-05-28 — Application filed
2015-09-01 — Assigned to examiner
2015-09-02 — Approved for pub - principal register
2015-09-23 — Notification of notice of publication e-mailed
2015-10-13 — Published for opposition
2015-10-13 — Official gazette publication confirmation e-mailed
2015-11-10 — Extension of time to oppose received
2016-02-11 — Opposition instituted no. 999999
2016-12-23 — Opposition terminated no. 999999
2016-12-23 — Opposition dismissed no. 999999
2016-12-23 — Ttab release case to trademarks
2017-02-07 — Noa e-mailed - sou required from applicant
2017-06-15 — Teas statement of use received
2017-06-15 — Use amendment filed
2017-07-11 — Case assigned to intent to use paralegal
2017-07-14 — Statement of use processing complete
2017-07-20 — Allowed principal register - sou accepted
2017-07-21 — Notice of acceptance of statement of use e-mailed
2017-08-22 — Registered-principal register
2022-08-22 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-03-08 — Cancelled sec. 8 (6-yr)
2024-03-08 — Final status recorded
Owner Information
SC HILCON SRL
Miercurea Ciuc RO
SC HILCON SRL
Miercurea Ciuc RO
SC HILCON SRL
Miercurea Ciuc RO
Correspondent
LAZAR CSABA SC HILCON SRL MIERCUREA CUIC STR LANCU DE HUNEDOARA, 33/A/4 ROMANIA
Filing Details
Filing Date:
2015-05-20
Status Date:
2024-03-08
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.